Rare diseases
Investigational molecules
Locations
Back to Germany607 clinical trials in Tuebingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
GermanyStudy on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer
GermanyStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
GermanyStudy of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment
GermanyStudy on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
GermanyStudy of BMS-986253 with Nivolumab and Ipilimumab for Patients with Advanced Solid Tumors
GermanyStudy Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma
GermanyStudy on the Safety and Effectiveness of GSKVX000000008866 and GSKVX000000009151 in Adults with Chronic Hepatitis B on Nucleotide Analogue Therapy
GermanyStudy comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer
GermanyStudy on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis
GermanyStudy on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on cutaneous lupus erythematosus and psoriatic arthritis, evaluating novel therapeutic approaches for managing chronic inflammatory conditions.
Studies aim to assess new treatment options for improving patient outcomes and quality of life.
Comprehensive studies on various cancer types, including metastatic prostate cancer and basal cell carcinoma, exploring innovative treatment combinations.
Research focuses on improving survival rates and developing more effective treatment strategies.
Groundbreaking research in multiple system atrophy and seizure disorders, investigating new therapeutic approaches for complex neurological conditions.
Clinical trials aim to enhance treatment options for patients with challenging neurological conditions.
Advanced research in eye disorders, including Leber congenital amaurosis and geographic atrophy, focusing on innovative treatment approaches.
Trials aim to preserve and improve vision in patients with rare and progressive eye conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
